Suppliers / Johnson Matthey Pharma Services

Johnson Matthey Pharma Services

United States Updated 9 July 2026

Johnson Matthey Pharma Services is an API manufacturer based in United States. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Bimatoprost US FDA 1

Also appears on these molecule pages

Bimatoprost API

Questions about Johnson Matthey Pharma Services

Does Johnson Matthey Pharma Services hold a US DMF or a CEP?
Johnson Matthey Pharma Services holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Johnson Matthey Pharma Services make?
1 molecule is on record against Johnson Matthey Pharma Services, including Bimatoprost. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Johnson Matthey Pharma Services comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule ScinoPharm Taiwan shares 1 molecule Industriale Chimica shares 1 molecule Newchem shares 1 molecule FDC Limited shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability